(Q42647908)

4 November 2017

title

Refinements in managing maternal weight adjustment for interpreting prenatal screening results (English)

1 reference

4 November 2017

Neveux LM

1

1 reference

4 November 2017

Palomaki GE

2

1 reference

4 November 2017

Larrivee DA

3

1 reference

4 November 2017

Knight GJ

4

1 reference

4 November 2017

Haddow JE

5

1 reference

4 November 2017

publication date

1 December 1996

1 reference

4 November 2017

1 reference

4 November 2017

volume

16

1 reference

4 November 2017

issue

12

1 reference

4 November 2017

page(s)

1115-1119

1 reference

Prenatal screening for Down's syndrome with use of maternal serum markers

4 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0223%28199612%2916%3A12%3C1115%3A%3AAID-PD3%3E3.0.CO%3B2-6

The effect of adjusting maternal serum alpha-fetoprotein levels for maternal weight in pregnancies with fetal open spina bifida. A United States collaborative study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0223%28199612%2916%3A12%3C1115%3A%3AAID-PD3%3E3.0.CO%3B2-6

Prospective intervention trial of a screening protocol to identify fetal trisomy 18 using maternal serum alpha‐fetoprotein, unconjugated oestriol, and human chorionic gonadotropin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0223%28199612%2916%3A12%3C1115%3A%3AAID-PD3%3E3.0.CO%3B2-6

Risk-based prenatal screening for trisomy 18 using alpha-fetoprotein, unconjugated oestriol and human chorionic gonadotropin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0223%28199612%2916%3A12%3C1115%3A%3AAID-PD3%3E3.0.CO%3B2-6

10.1002/(SICI)1097-0223(199612)16:12<1115::AID-PD3>3.0.CO;2-6

21 January 2018

Identifiers

DOI

1 reference

4 November 2017

1 reference